FDA approval expands treatment options for people with metastatic breast cancer that expresses minimal levels of HER2.

by Sandra Gordon

After caring for her husband during his cancer treatment, Miriam Díaz-Gilbert was prepared to face her DCIS diagnosis.

by Miriam Díaz-Gilbert

Reports on breast density inform women of their status but raise questions about what to do next.

by Robin Roenker

Giving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.

by Laura Gesualdi-Gilmore